Publications
- Sarcopenia in Metastatic Renal Cell Carcinoma Patients Treated with Cabozantinib2020 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Klinická onkologie2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Favorable prognostic significance of membranous β-catenin expression and negative prognostic significance of cytoplasmic β-catenin expression in pancreatic cancer2023 | First Faculty of Medicine, Third Faculty of Medicine
- Sacituzumab govitecan in the treatment of triple negative breast cancer2023 | First Faculty of Medicine
- Serum markers in diagnosing prostate cancer2023 | First Faculty of Medicine
- Body composition changes during and after curative chemotherapy in patients with testicular cancer2022 | First Faculty of Medicine, Third Faculty of Medicine
- Patients with metastatic renal cell carcinoma treated with cabozantinib in the Czech Republic: analysis of four cancer centers2022 | First Faculty of Medicine
- Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...